Abstract
Background
Long‐term air pollution exposure is a significant risk factor for inpatient hospital admissions in the general population. However, we lack information on whether long‐term air pollution exposure is a risk factor for hospital readmissions, particularly in individuals with elevated readmission rates.
Methods and Results
We determined the number of readmissions and total hospital visits (outpatient visits+emergency room visits+inpatient admissions) for 20 920 individuals with heart failure. We used quasi‐Poisson regression models to associate annual average fine particulate matter at the date of heart failure diagnosis with the number of hospital visits and 30‐day readmissions. We used inverse probability weights to balance the distribution of confounders and adjust for the competing risk of death. Models were adjusted for age, race, sex, smoking status, urbanicity, year of diagnosis, short‐term fine particulate matter exposure, comorbid disease, and socioeconomic status. A 1‐µg/m3 increase in fine particulate matter was associated with a 9.31% increase (95% CI, 7.85%–10.8%) in total hospital visits, a 4.35% increase (95% CI, 1.12%–7.68%) in inpatient admissions, and a 14.2% increase (95% CI, 8.41%–20.2%) in 30‐day readmissions. Associations were robust to different modeling approaches.
Conclusions
These results highlight the potential for air pollution to play a role in hospital use, particularly hospital visits and readmissions. Given the elevated frequency of hospitalizations and readmissions among patients with heart failure, these results also represent an important insight into modifiable environmental risk factors that may improve outcomes and reduce hospital use among patients with heart failure.
Keywords: 30‐day readmissions, air pollution, electronic health records, heart failure, hospital use, PM2.5
Subject Categories: Heart Failure, Risk Factors, Epidemiology
Nonstandard Abbreviations and Acronyms
- PM2.5
Particulate matter <2.5 µm in diameter
Clinical Perspective
What Is New?
Elevated long‐term air pollution has been associated with inpatient hospital admissions but has not been evaluated for readmission risk or outpatient visits.
What Are the Clinical Implications?
Elevated air pollution exposure among patients with heart failure increases 30‐day readmissions, outpatient visits, and inpatient admissions, pointing to an overall increase in morbidity with increasing exposure.
Air quality may be an important risk factor for readmissions as well as increased hospital use and may impact readmission rates for hospitals serving areas with poor air quality.
Heart failure (HF) represents one of the most severe forms of cardiovascular diseases. As a clinical syndrome, it is marked by a progression through 4 stages, where in the final stage symptoms such as shortness of breath, fatigue, and swelling, all of which result from myocardium disorders, are present with minimal activity or even at rest. 1 In the United States, the prevalence of HF is increasing, and by 2030, an estimated 8 million individuals will have HF, a 46% increase from 2012. 1 , 2 This rise in HF prevalence will bring along a substantial rise in HF burden on the healthcare system both in terms of hospital use and total costs. In 2012, the total cost of HF in the United States was estimated at $30.7 billion, with approximately 68% of those costs coming from direct healthcare costs such as hospital visits and inpatient stays. 1 , 3 By 2030, the cost of HF is estimated to grow to $69.8 billion, a 127% increase. 2
Much of the costs and patient burden of HF is tied to increased healthcare use, particularly hospital visits. One study estimated that 83% of patients with HF would be hospitalized at least once after diagnosis, and 43% would be hospitalized 4 or more times. 4 Although overall hospitalization rates appear to be declining (29.5% decline from 1998 to 2007), this decline was heterogeneous across race, sex, and state of primary residence. 5 Hospital readmissions are also high among patients with HF, particularly 30‐day readmissions, which are used to evaluate quality of care. In 2012, 30‐day readmissions among individuals with HF was 19%, only a slight decrease from the 30‐day readmission rates of 20% seen in 2009. 6 This rate is also nearly twice the 30‐day readmission rate of 11.6% seen for the general US population. 7 Elevated 30‐day readmission rates can be particularly important for hospital systems given the substantial penalties imposed under the Hospital Readmission Reduction Program in the Affordable Care Act. In this program, up to 3% of Centers for Medicare and Medicaid Services fee‐for‐service payments can be withheld for elevated 30‐day readmissions for HF and 5 other conditions, which is estimated to result in hundreds of millions of dollars in penalties in the 2020 fiscal year. Thus, there is a substantial need for patients, hospital systems, and public health officials alike to understand the risk factors for hospitalizations and readmissions among patients with HF.
Long‐term exposure to air pollution has been understudied as a risk factor for hospitalizations and readmissions, relative to short‐term exposures. 8 , 9 In a recent study, elevated long‐term exposure to particulate matter <2.5 µm in diameter (PM2.5) was associated with an increased likelihood of an inpatient admission among the Medicare population, even in areas with PM2.5 concentrations below the current annual National Ambient Air Quality Standard of 12 µg/m3. 10 However, there has not yet been a study of the increased number of 30‐day readmissions and total hospital visits (outpatient visits+emergency room visits+inpatient admissions) associated with poor air quality, which may be of particular importance for vulnerable individuals with preexisting cardiovascular disease. Thus, we sought to evaluate the association between annual average PM2.5 exposure and the number of 30‐day readmissions and hospital visits after a diagnosis of HF.
Methods
The data that support the findings of this study are available from the corresponding author upon reasonable request and approval of the appropriate institutional review board.
Study Population
The population for this study came from the Environmental Protection Agency Clinical and Archived Records Research for Environmental Studies (EPA CARES) research resource, a resource of electronic health records merged with environmental exposure data to facilitate environmental health studies of patient populations. 11 All electronic health records came from the University of North Carolina Healthcare System. This study was approved by the institutional review board of the University of North Carolina–Chapel Hill (IRB 17‐0150), and informed consent was waived for this analysis of existing health records. We required primary addresses to be geocoded at the street level, and excluded all individuals who reported being homeless or who reported a prison or hospital as their primary address. We determined the date of initial HF diagnosis on the basis of the individual’s electronic health records. We required individuals to have at least one hospital visit before their HF diagnosis, we removed people who were diagnosed at other hospital systems but entered the University of North Carolina Healthcare System later, and we retained all individuals with an initial HF diagnosis between July 1, 2004 and December 31, 2016, the time period of our study.
Exposures
For this study we used daily PM2.5 predictions from an ensemble machine‐learning model that has been well validated, with an R 2 of 0.89 for the mid‐Atlantic region, which includes North Carolina, 12 and was used in a previous study of the Environmental Protection Agency Clinical and Archived Records Research for Environmental Studies resource. 11 Briefly, the model incorporates multiple machine‐learning algorithms to integrate land‐use variables, meteorology, chemical transport models, ground‐based monitoring, and aerosol optical depth measurements from satellites to estimate PM2.5 concentrations at a 1‐km2 resolution for the continental United States. We linked each individual to a 1‐×1‐km grid cell on the basis of their primary address location. After matching each participant to the appropriate grid cell, daily air pollution values were averaged into an annual average (mean of prior 365 days) based on their date of HF diagnosis.
Statistical Analysis
For our study, we defined a hospital visit as an inpatient admission, emergency room visit, or outpatient visit to the hospital. Emergency room visits that resulted in an inpatient admission were grouped with inpatient admissions to prevent double counting. Multiple visits on the same calendar day were collapsed into a single visit to prevent overcounting because of transfers between hospital departments. A N‐day readmission is defined as any inpatient admission whose admission date was within N days of the discharge date for a preceding inpatient admission. To limit overcounting because of transfers between departments, hospitalizations where the discharge date was the same as the admission date for the subsequent hospitalization were merged into a single hospitalization. Our primary outcomes were the number of 30‐day readmissions and the number of total hospital visits observed from the initial diagnosis of HF until the end of the study observation time (December 31, 2016). We also examined associations with the number of inpatient admissions and emergency room visits, as well as the number of 7‐, 60‐, and 90‐day readmissions experienced by each individual from initial HF diagnosis until the end of the observation time.
We used quasi‐Poisson models that adjusted for age, race, sex, year of HF diagnosis, smoking status (current, former, never, or unknown), neighborhood socioeconomic status, percent urbanicity of the 2010 census block group in which the individual resided, preexisting chronic disease, and short‐term air pollution exposure. Log‐transformed follow‐up time in years was included as an offset. We refer to this model as the Primary model to distinguish it from subsequent models and sensitivity analyses. Beause 36% of individuals had an unknown smoking status, we undertook a sensitivity analysis where we used multiple‐imputation chained equations as implemented in the mice package in R 13 to impute the missing smoking status based on the rest of the available data. We imputed 5 data sets and then compared original associations with associations obtained using each imputation of smoking status as well as pooled estimates from all 5 imputations. The neighborhood socioeconomic status variables were all assessed at the block group level using the 2010 census block groups and were median household income, median home value, percent of block group on public assistance, and percent of block group residents below the federal poverty line. All neighborhood socioeconomic status variables were included as separate variables in the models. To adjust for short‐term air pollution exposure, we included the mean of the 5‐day average PM2.5 concentration. The 5‐day average PM2.5 was calculated as the mean of the PM2.5 concentration on the day of each hospital visit and the 4 days before each hospital visit. To adjust for potential confounding by preexisting chronic disease, we adjusted for a diagnosis of chronic kidney disease, peripheral arterial disease, type 2 diabetes mellitus, chronic obstructive pulmonary disease, ischemic heart disease, dyslipidemia, and hypertension in all models, which may make our estimates conservative, because some chronic conditions are also associated with long term PM2.5 exposure. Preexisting conditions were defined by International Classification of Diseases, Ninth Revision (ICD‐9) and Tenth Revision (ICD‐10) codes, which are detailed in Data S1.
Because electronic health records and census data only partially captured the socioeconomic and behavioral characteristics used, we added an Extended model, which included all terms from the Primary model, including adjustment for preexisting conditions, as well as an additional 20 county‐level variables from the 2015 County Health Rankings from the University of Wisconsin Population Health Institute and the Robert Wood Johnson Foundation 14 to the Primary model described above. We chose the 2015 data because they contained the county‐level variables that best supplemented the electronic health record data, and county data were sampled in 2006 to 2014, which overlapped well with our observation period. The variables chosen captured access to health care, healthcare costs, crime, physical activity, employment, access to healthy foods, income inequality, and public water system violations. The full list of the county‐level measures included in the additional adjustment along with their distribution in the study cohort is given in Table S1.
Given that there is a high mortality rate among individuals with HF, we used stabilized inverse probability weights to account for the competing risk of death, as done in a similar study of inpatient admissions. 10 The stabilized inverse probability weights also included weights for the distribution of confounders that would act to better balance the distribution of confounders across the exposure distribution, which can also allow for causal interpretations subject to certain assumptions. We estimated the standardized difference in the inverse probability weights to determine the degree of imbalance between the upper and lower quartiles of the PM2.5 distribution. We classified the imbalance as very weak (0–0.2), weak (0.2–0.4), moderate (0.4–0.6), or strong (>0.6), which follows published guidelines. 15 Moderate or even strong categories of the standardized difference do not invalidate models but do indicate that causal interpretations require further investigation, because the assumption of positivity, required for causal interpretations of associations from observational studies, is likely violated. The other 2 assumptions needed for causal interpretations are no unmeasured confounding and the stable unit treatment value assumption. The stable unit treatment value assumption captures the principle of no interference, which states that the potential outcome for any individual does not depend on the treatment (here the annual average PM2.5 exposure) received by other individuals, and the principle of consistency, which is the assumption that all treatments can be considered equivalent. The stable unit treatment value assumption and no unmeasured confounding can often not be tested for directly, and the reasonableness of these assumptions is typically evaluated on the basis of the treatment, outcome, and study design.
We stratified associations on age at HF diagnosis (<65 years versus ≥65 years), race, sex, the median income of each census block groups (<$49 318 versus ≥$49 318), and the percent urbanicity of each census block group. For stratification on income, we examined individuals residing in US census block groups with below median income (<$49 318, low income) versus those residing in census block groups with above median income (≥$49 318, high income). For stratifications on urbanicity, we classified individuals living in the bottom third of the block group urbanicity distribution (<38% urban) as rural, and compared associations with all other individuals (nonrural). Urbanicity was defined according to the 2010 US Census (https://www.census.gov/programs‐surveys/geography/guidance/geo‐areas/urban‐rural/2010‐urban‐rural.html), which classified areas as urban if the area encompassed at least 2500 individuals. We also examined stratifications by PM2.5 concentration by restricting to those individuals with PM2.5 concentrations <12 µg/m3.
To guard against late‐age HF diagnoses or potential birthday entry errors, we performed a sensitivity analysis restricting to those <100 years old at the end of observation. As previously mentioned, we also performed sensitivity analyses using multiple imputation by chained equations to impute missing smoking status and compare associations across imputations and in the pooled imputations.
For the readmissions outcomes, we also added a sensitivity analysis that removed readmissions following an inpatient admission lasting 0 days or zero‐length readmissions, which we defined as a readmission where the individual was admitted and discharged on the same day. Given that only 20.9% of inpatient admissions resulted in a 30‐day readmission, similar to readmission rates seen in other studies of patients with HF, 6 we also implemented a zero‐inflated Poisson model using the pscl package 16 in R. We used an intercept‐only model to model the excess number of zeros in the distribution and assumed the true counts came from a model with the confounder adjustments as previously described. As with the Primary model, log‐transformed follow‐up time in years was included as an offset. The output of the zero‐inflated Poisson model has the same interpretation as the quasi‐Poisson model used in the Primary model. We used R version 3.5.1 17 for all analyses. Results are presented as the percent change per 1 µg/m3 increase in annual average PM2.5 and the associated 95% CI. Percent change was calculated as (e β‐1)*100, where β is the regression coefficient from the quasi‐Poisson or zero‐inflated Poisson model and e is the base of the natural logarithm.
Results
The final study population was 20 920 individuals. We observed 442 244 hospital visits over an average follow‐up of 2.79 year (7.6 visits per person‐year). The total number of visits included emergency room visits (7.3%, 69% of which resulted in an inpatient admission), inpatient admissions (7.1%), and outpatient visits (91%). As mentioned in the Methods, emergency room visits resulting in an inpatient admission were considered inpatient admissions to avoid double counting. There were 12 474 individuals with a valid inpatient admission and who could thus qualify to have a readmission. Among these individuals, we observed 1739 seven‐day readmissions; 7114 thirty‐day readmissions; 10 612 sixty‐day readmissions, and 12 624 ninety‐day readmissions. Descriptions of the overall cohort and those with an inpatient admission are given in Table 1. We examined the distribution of readmissions, and to combat outliers, we removed all individuals with 10 or more readmissions for each readmission window, which removed 0.07% of 7‐day readmissions, 0.49% of 30‐day readmissions, 0.96% of 60‐day readmissions, and 1.27% of 90‐day readmissions. For the total number of visits, we removed outliers by removing individuals whose number of visits was more than the third quartile plus 1.5*interquartile range (55.5 visits, 9.4% observations removed). No individuals fell below the first quartile minus 1.5*interquartile range in the distribution of outpatient visits; hence, only upper outliers were removed. Violin plots showing the distribution of total visits and 30‐day readmissions by year are given in Figure S1.
Table 1.
Study Cohort
| Study Cohort, N=20 920 | Inpatient Admission Cohort, N=12 474 | |||
|---|---|---|---|---|
| Mean | SD | Mean | SD | |
| Age, y | 68.8 | 14.8 | 69.0 | 15.1 |
| Urbanicity, % | 63.6 | 41.9 | 64.9 | 41.5 |
| Median home value, $ | 182 744 | 107 940 | 193 088 | 111 825 |
| Households below federal poverty line, % | 17.0 | 14.0 | 16.6 | 14.0 |
| Public assistance, % | 1.98 | 2.97 | 1.96 | 2.95 |
| Total visits, n | 14.2 | 14.3 | 16.4 | 15.5 |
| Outpatient visits, n | 12.4 | 13.1 | 13.6 | 14.3 |
| Inpatient admissions, n | 1.34 | 1.77 | 2.29 | 1.79 |
| Emergency visits, n | 1.16 | 1.82 | 1.90 | 2.05 |
| 7‐d readmissions, n | 0.12 | 0.48 | 0.12 | 0.48 |
| 30‐d readmissions, n | 0.49 | 1.10 | 0.49 | 1.10 |
| 60‐d readmissions, n | 0.70 | 1.36 | 0.70 | 1.36 |
| 90‐d readmissions, n | 0.81 | 1.50 | 0.81 | 1.50 |
| Follow‐up time, n | 2.79 | 3.05 | 3.02 | 3.21 |
| PM2.5, μg/m3 | 9.87 | 1.75 | 10.2 | 1.84 |
| N | % | N | % | |
|---|---|---|---|---|
| Women | 10 998 | 52.6 | 6657 | 53.4 |
| Men | 9922 | 47.4 | 5817 | 46.6 |
| Race, White | 13 875 | 66.3 | 8345 | 66.9 |
| Race, Black | 5564 | 26.6 | 3423 | 27.4 |
| Race, other | 1481 | 7.08 | 706 | 5.66 |
| Never smoker | 6176 | 29.5 | 3244 | 26.0 |
| Former smoker | 6515 | 31.1 | 3607 | 28.9 |
| Current smoker | 2029 | 9.70 | 1222 | 9.80 |
| Unknown smoking status | 6200 | 29.6 | 4401 | 35.3 |
| Chronic kidney disease | 13 183 | 63.0 | 8505 | 68.2 |
| Ischemic heart disease | 13 438 | 64.2 | 8650 | 69.3 |
| Hypertension | 16 602 | 79.4 | 10 275 | 82.4 |
| Chronic obstructive pulmonary disorder | 9025 | 43.1 | 5930 | 47.5 |
| Type 2 diabetes mellitus | 7627 | 36.5 | 4947 | 39.7 |
| Dyslipidemia | 17 042 | 81.5 | 10 490 | 84.1 |
| Peripheral arterial disease | 9229 | 44.1 | 5969 | 47.9 |
The overall study cohort is described, as well as those with at least one inpatient admission, who thus formed the basis for the study of readmissions. "Race, other" refers to individuals who did not self‐identify as Black or White race.
Associations With Total Visits
A 1‐µg/m3 increase in annual average PM2.5 was associated with a 9.31% (95% CI, 7.85%–10.8%; Figure 1, Table 2, Figure S2) increase in the number of hospital visits. There was minimal difference in the associations with inclusion of an additional 20 county‐level variables to adjust for healthcare access, behavioral, and socioeconomic features not well captured in electronic health records (Table 2). Associations were virtually unchanged in 5 imputations of the missing smoking information (Figure S3). Associations with total visits were observed across stratifications by age, income, race, sex, and urbanicity, and were strongest among Black participants and those diagnosed with HF before the age of 65 years (Figure 1, Table S2). The mean number of total visits by each stratification did not differ substantially (Table S3). Associations remained present even for individuals with exposures below the current PM2.5 national standard (7.16% increase; 95% CI, 5.29%–9.06%), and sensitivity analyses did not reveal substantial differences in associations (Table 2).
Figure 1. Associations between annual average particulate matter <2.5 µm in diameter (PM2.5) and hospital visits.

The percent change in hospital visits is given per 1‐µg/m3 increase in annual average PM2.5. The gray shaded area represents the range of values for the 95% CI for associations in the overall cohort (All). Low Income refers to participants living in census block groups where the median income of that census block group is less than the median of all census block groups represented by participants within the study. High Income refers to participants living in census block groups where the median income is higher than the median of all census block groups represented by participants within the study. Rural refers to participants living in census block groups in the bottom third of the urbanicity (% of census block group that is urban) distribution, and Non‐rural refers to all other participants (upper two thirds or urbanicity distribution). Age refers to the age at heart failure diagnosis. Models were adjusted using the Primary model adjustment as described in the Methods.
Table 2.
Sensitivity Analyses for Total Visits
| Sensitivity Analysis | Percent Change | LCI | UCI |
|---|---|---|---|
| Participants with age <100 y at end of observation | 9.20 | 7.74 | 10.7 |
| Extended model | 11.4 | 9.88 | 13.0 |
Associations remained in sensitivity analyses restricting based on age as well as in the Extended model. The Primary model adjusted for age, race, sex, year of heart failure diagnosis, smoking status, median home value for the census block group, median household income for the census block group, percent of households on public assistance in the census block group, percent of households below the federal poverty line for the census block group, preexisting conditions, and short‐term PM2.5 exposure. The Extended model adjusted the Primary model for an additional 20 county‐level behavioral, socioeconomic, and healthcare access variables (Table S1). LCI, indicates lower 95% CI; and UCI, upper 95% CI.
When broken down by visit type, we observed associations for outpatient visits (9.87% increase; 95% CI, 8.41%–11.4%), inpatient admissions (4.35% increase; 95% CI, 1.12%–7.68%), and emergency department visits (10.0% increase; 95% CI, 6.40%–13.8%). To provide a more complete picture of associations with emergency department use, we regrouped visits, creating a category of all emergency department visits whether they resulted in an inpatient admission or not, and still observed associations (4.18% increase; 95% CI, 0.56%–7.93%).
Associations With Readmissions
A 1‐µg/m3 increase in annual average PM2.5 exposure was associated with a 14.2% increase in 30‐day readmissions (95% CI, 8.4%–20.2%; Figure 2, Table 3, Figure S4). As with total visits, associations between annual average PM2.5 exposure and 30‐day readmissions were strongest among Black participants and those diagnosed with HF before the age of 65 years (Figure 2, Table S4). The mean and standard deviation for 30‐day readmissions were highly similar across each subgroup for the stratified analyses (Table S3). Imputation of the missing smoking information slightly attenuated associations; however, there was stronger overlap of the 95% CIs for the Primary model and models with imputed data, indicating high agreement across all models (Figure S5). Associations remained in the sensitivity analyses, and were somewhat stronger in the Extended model, which included an additional 20 county‐level behavioral and socioeconomic indicators (Table 3). We did not observe associations with 30‐day readmissions when restricting to PM2.5 exposures <12 µg/m3 (Figure 2; Table S4).
Figure 2. Associations between annual average particulate matter <2.5 µm in diameter (PM2.5) and 30‐day readmissions.

The percent change in hospital visits is given per 1‐µg/m3 increase in annual average PM2.5. The gray shaded area represents the range of values for the 95% CI for associations in the overall cohort (All). Low Income refers to participants living in census block groups where the median income of that census block group is less than the median of all census block groups represented by participants within the study. High Income refers to participants living in census block groups where the median income is higher than the median of all census block groups represented by participants within the study. Rural refers to participants living in census block groups in the bottom third of the urbanicity (% of census block group that is urban) distribution, and Non‐rural refers to all other participants (upper two thirds or urbanicity distribution). Age refers to the age at heart failure diagnosis. All models used the Primary model adjustment as described in the Methods.
Table 3.
Sensitivity Analyses for 30‐Day Readmissions
| Sensitivity Analysis | Percent Change | LCI | UCI |
|---|---|---|---|
| Zero‐length readmissions removed | 10.5 | 4.50 | 16.8 |
| Participants with age <100 y at end of observation | 13.6 | 7.92 | 19.7 |
| Extended model | 17.6 | 11.6 | 23.9 |
| Zero‐inflated Poisson | 8.43 | 5.48 | 11.5 |
Associations were attenuated when restricting to individuals who reported only a single address, and thus are assumed to have never moved; however, this might have been driven by the reduced sample size, which is highlighted by the increased width of the 95% CI. The zero‐length readmissions removed sensitivity analysis refers to removing all hospital admissions where the individual was admitted and discharged on the same day and then recalculating the number of 30‐day readmissions. The Primary model adjusted for age, race, sex, year of heart failure diagnosis, smoking status, median home value for the census block group, median household income for the census block group, percent of households on public assistance in the census block group, percent of households below the federal poverty line for the census block group, preexisting conditions, and short‐term PM2.5 exposure. The Extended model adjusted the Primary model for an additional 20 county‐level behavioral, socioeconomic, and healthcare access variables (Table S1). LCI, indicates lower 95% CI; and UCI, upper 95% CI.
We also observed associations between annual average PM2.5 exposure and the number of 7‐ (28.3%; 95% CI, 17.5%–40.1%), 60‐ (12.3%; 95% CI, 7.49%–17.3%), and 90‐day (13.0%; 95% CI, 8.55%–17.7%) readmissions. As with 30‐day readmissions, associations for the other readmission windows were not observed for exposure below the current 12‐µg/m3 PM2.5 national standard (Figure 3). Associations with 7‐, 60‐, and 90‐day readmissions remained when removing admissions with same‐day discharges as well in zero‐inflated Poisson models (Table S5).
Figure 3. Associations between annual average particulate matter <2.5 µm in diameter (PM2.5) and hospital readmissions.

Associations are shown for each readmission window and for the entire study cohort (All) as well as for those with annual average PM2.5 exposure less than current national standards (PM2.5<12 µg/m3).
Discussion
We observed that long‐term exposure to particulate matter air pollution substantially increases hospital visits (both outpatient visits and inpatient admissions) as well as readmissions among patients with HF. These associations give a key insight into the morbidity effects of long‐term exposure to air pollution for individuals with HF. The biological mechanisms that likely underlie these associations have been well established and include systemic inflammation, increased activation of the autonomic nervous system, and oxidative stress induced by penetration of PM2.5 particles into the respiratory tract. 18 , 19 , 20
Total Visits
A 1‐µg/m3 increase in annual average PM2.5 was associated with a 9.50% increase in total hospital visits. Because the majority of hospital visits were outpatient visits, this association was driven by outpatient visits where we saw a similar association. This is one of the first studies to examine long‐term air pollution exposures in relation to total hospital visits and outpatient visits, as opposed to just inpatient admissions. Outpatient hospital visits are often scheduled visits and would include routine visits as well as visits because of an illness, but not one threatening enough to warrant a visit to the emergency room. Thus, associations with outpatient visits possibly indicate associations with general increases in morbidity and illnesses causing greater use of hospital services. We also saw associations with emergency room visits indicating that multiple forms of hospital use are elevated by long‐term PM2.5 exposure. A study of HF hospitalization rates from 1998 to 2008 found that although rates declined by nearly 30%, Black men experienced the smallest decline. 5 We also observed that Black patients with HF had the highest associations between total hospital visits and long‐term air pollution exposure (Figure 1), and the association was 40% higher in Black patients with HF as opposed to White patients with HF. The racial disparity was even larger for 30‐day readmissions (Figure 2, Table S3). Given that minorities are often exposed to higher levels of air pollution than nonminority populations, it is possible that some of the racial health disparities seen in patients with HF are in part driven by environmental factors like air pollution. We observed substantial sex differences with female patients with HF having stronger associations with total visits than male patients with HF. This has not been previously reported, and further work is warranted to understand if these differences are driven by differential exposures, possibly because of different time‐activity patterns, or other factors. We also observed differences by age at HF diagnosis with individuals <65 years old having larger associations than older individuals. Early onset cardiovascular disease is associated with a strong genetic component, 21 and gene‐by‐air pollution interactions have been shown for many cardiovascular outcomes. 22 Thus, differences by age at HF diagnosis may reflect genetic components to the underlying HF, which confer more environmental sensitivity. Healthcare access has a large role in determining rates of outpatient visits and total hospital visits. However, associations remained when adjusting for the average annual healthcare cost, number of primary physicians per 100 000 people, number of non–primary care physicians per 100 000 people, and the number of mental health providers per 100 000 people in the Extended model (Table 2). We also did not observe consistent, substantial differences in the number of visits and 30‐day readmissions across the stratified analyses, which otherwise could have been an explanation for differences seen in the stratified analyses (Table S3).
Inpatient Admissions and Readmissions
There are few existing studies that have examined associations between long‐term air pollution exposure and inpatient hospital admissions. In a study of Medicare recipients in the Southeast region of the United States, a 1‐µg/m3 increase in annual average PM2.5 was associated with a 5.3% increased risk of an inpatient hospital admission for HF. 10 This is similar to the 4.35% increase (95% CI, 1.12%–7.68%) observed for inpatient admissions in this study. This similarity increases our confidence that our results may generalize to other HF populations.
In addition to hospital admissions, we also examined readmissions that have not been commonly examined in relation to environmental exposures. Thirty‐day hospital readmissions are a closely watched measure that is used to evaluate the quality of hospital operations, and there have been recent national campaigns to lower readmission rates by 20%. 23 In our study, annual average PM2.5 exposure was associated with a 14.1% increase in the number of 30‐day readmissions, suggesting that a portion of 30‐day readmissions may be influenced by long‐term air pollution exposure. Annual average PM2.5 exposure was also associated with the number of 7‐, 60‐, and 90‐day readmissions. These associations represent some of the first insights into long‐term air pollution exposures and readmission risks. Understanding the association between readmissions and potentially modifiable risk factors like air pollution is particularly important for patients with HF, because they have high 30‐day readmission rates. 6 A nationwide study found a minor decline in 30‐day all‐cause readmission rates between 2009 and 2012, and only 1.4% of hospitals examined achieved the 20% decline in relative 30‐day readmission rates targeted by quality‐improvement campaigns. No hospital achieved a 20% decline in 60‐day readmission rates. 6 Although the study did find that hospitals that referred patients to HF disease management programs had lower readmission rates, they did not evaluate if environmental conditions might have contributed to readmission rates.
Strengths and Limitations
One of the primary strengths of this study is the large sample size and use of electronic health records to estimate the number of outpatient hospital visits, inpatient admissions, and 30‐day readmissions within patients with HF. Patients with HF have previously been shown to have elevated environmental health risks, 11 and they have high hospital use and readmission rates, making them an ideal population to study for environmental determinants of hospital visits. One drawback of electronic health records is that not all confounders typically captured in an epidemiological study are represented within them. We used a combination of medical records data, census data, and county‐level health data to perform a broad adjustment for potential confounders. We did not observe substantial differences in the association when adding additional potential confounders beyond our Primary model, indicating a robustness to confounding that has been demonstrated in previous similar studies. 10 Because we used only a single hospital system located in North Carolina, these results may not generalize to HF populations in other states. However, we found good agreement when comparing associations with inpatient admissions in our study and a comparable analysis of inpatient admissions for over 11 million Medicare recipients in the southeastern United States. Other limitations of electronic health record analyses include the use of ICD‐9 and ICD‐10 codes for disease definitions and potential changes in the underlying software/technology that captures and stores the medical information. Although limited, ICD‐9 and ICD‐10 codes present the single broadest possible capture of disease history in the electronic medical record. We also eliminated codes listed as billing or diagnostic to refine determinations of HF and preexisting disease. Our models included an adjustment for time that can capture changes in technology over time. We also examined restricting to records before 2014 and adjusting for this time period because the University of North Carolina Healthcare System underwent a change in health‐record management software around that time. There were no substantial differences in visits or readmissions for patients diagnosed before versus after 2014 (Figure S1), and neither restriction nor adjustment for this potential change altered results, so we proceeded with the analysis as described. However, because our study observation time ended on December 31, 2016, it is possible that gathering more data might reveal some differences as compared with earlier records, which should be carefully considered and accounted for in future analyses. Because the primary reason for most visits was recorded as HF, we did not do a breakdown by reason for visit. Future advancements in medical record capture may allow for this important aspect of these associations to be explored. Although we did not observe differences in hospital visits or 30‐day readmission rates across the stratified analyses (Table S3), associations may not generalize to populations with limited access to health care, and stratified analyses should be interpreted carefully. North Carolina had air quality generally just below the current PM2.5 national standard, allowing us to examine associations below the standard, providing useful information on association in low‐exposure scenarios. A strength of the study is the stabilized inverse probability weights used to allow for causal interpretations of results. Although there was a moderate violation of the positivity assumption for the 30‐day readmissions in the Primary model, as shown by the moderate differences in weights (Table S3), this was not observed in the Extended model, and there were little to no violations seen for total visits in either model (Table S2). In addition to positivity, causal interpretations of associations from observational studies require the additional assumptions of no unmeasured confounding and stable unit treatment value assumption, that is, that exposure to one individual does not alter associations for others, and all exposures can be treated equally. Although the treatment of all ambient PM2.5 concentrations is the same, and the assumption that one individual’s exposure does not alter responses of an independent individual are considered reasonable in these studies, the assumption of no unmeasured confounding requires careful consideration. Although we did adjust for a broad array of confounders in the Primary model, and did not observe differences when adding 20 additional confounders in the Extended model, it is always impossible to conclude with certainty that associations are not impacted by unmeasured confounding. However, these unmeasured confounders would need to be largely independent of all 37 confounders considered in the Extended model to alter associations and causal interpretations.
In conclusion, we observed that long‐term exposure to particulate air pollution is associated with substantial increases in total hospital visits, outpatient visits, inpatient admissions, as well as 7‐, 30‐, 60‐, and 90‐day readmissions in individuals with HF. These associations expand our knowledge of the relationship between air quality and hospital use and highlight the potential for long‐term environmental exposure to play a role in readmission rates.
Sources of Funding
Funding for this project came in part from the US Environmental Protection Agency, including Harvard participants grant RD‐835872‐01. This article does not necessarily represent the view or policies of the US Environmental Protection Agency. Any mention of trade names or copyright does not constitute endorsement. This project was in part supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) through grant award number UL1TR002489. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Disclosures
Dr Cavin Ward‐Caviness is a paid advisor for the nonprofit Clock Foundation. The Clock Foundation had no role in the data collection, study design, data analysis, interpretation, or writing of this manuscript.
Supporting information
Data S1
Tables S1–S5
Figures S1–S5
Acknowledgments
The authors would like to acknowledge Emily Pfaff for her work in compiling electronic health records for the Environmental Protection Agency Clinical and Archived Records Research for Environmental Studies resource used in this study.
(J Am Heart Assoc. 2021;10:e019430. DOI: 10.1161/JAHA.120.019430.)
Supplementary Material for this article is available at https://www.ahajournals.org/doi/suppl/10.1161/JAHA.120.019430.
For Sources of Funding and Disclosures, see page 10.
References
- 1. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, et al. Forecasting the impact of heart failure in the United States. Circulation. 2013;6:606–619. DOI: 10.1161/HHF.0b013e318291329a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al. Heart disease and stroke statistics‐2020 update: a report from the American Heart Association. Circulation. 2020;141:e139–e596. DOI: 10.1161/CIR.0000000000000757. [DOI] [PubMed] [Google Scholar]
- 3. Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol. 2014;171:368–376. DOI: 10.1016/j.ijcard.2013.12.028. [DOI] [PubMed] [Google Scholar]
- 4. Dunlay SM, Redfield MM, Weston SA, Therneau TM, Hall Long K, Shah ND, Roger VL. Hospitalizations after heart failure diagnosis. J Am Coll Cardiol. 2009;54:1695–1702. DOI: 10.1016/j.jacc.2009.08.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Chen J, Normand S‐LT, Wang Y, Krumholz HM. National and regional trends in heart failure hospitalization and mortality rates for medicare beneficiaries, 1998‐2008. JAMA. 2011;306:1669–1678. DOI: 10.1001/jama.2011.1474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Bergethon KE, Ju C, DeVore AD, Hardy NC, Fonarow GC, Yancy CW, Heidenreich PA, Bhatt DL, Peterson ED, Hernandez AF. Trends in 30‐day readmission rates for patients hospitalized with heart failure: findings from the get with the guidelines‐heart failure registry. Circ Heart Fail. 2016;9. DOI: 10.1161/CIRCHEARTFAILURE.115.002594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Berry JG, Gay JC, Joynt Maddox K, Coleman EA, Bucholz EM, O’Neill MR, Blaine K, Hall M. Age trends in 30 day hospital readmissions: US national retrospective analysis. BMJ. 2018;360:k497. DOI: 10.1136/bmj.k497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, Samet JM. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA. 2006;295:1127–1134. DOI: 10.1001/jama.295.10.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Larrieu S, Jusot J‐F, Blanchard M, Prouvost H, Declercq C, Fabre P, Pascal L, Tertre AL, Wagner V, Rivière S, et al. Short term effects of air pollution on hospitalizations for cardiovascular diseases in eight French cities: the PSAS program. Sci Total Environ. 2007;387:105–112. DOI: 10.1016/j.scitotenv.2007.07.025. [DOI] [PubMed] [Google Scholar]
- 10. Danesh Yazdi M, Wang Y, Di Q, Zanobetti A, Schwartz J. Long‐term exposure to PM2.5 and ozone and hospital admissions of Medicare participants in the Southeast USA. Environ Int. 2019;130:104879. DOI: 10.1016/j.envint.2019.05.073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Ward‐Caviness CK, Weaver AM, Buranosky M, Pfaff ER, Neas LM, Devlin RB, Schwartz J, Di Q, Cascio WE, Diaz‐Sanchez D. Associations between long‐term fine particulate matter exposure and mortality in heart failure patients. J Am Heart Assoc. 2020;9:e012517. DOI: 10.1161/JAHA.119.012517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Di Q, Amini H, Shi L, Kloog I, Silvern R, Kelly J, Sabath MB, Choirat C, Koutrakis P, Lyapustin A, et al. An ensemble‐based model of PM2.5 concentration across the contiguous United States with high spatiotemporal resolution. Environ Int. 2019;130:104909. DOI: 10.1016/j.envint.2019.104909. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. van Buuren S, Groothuis‐Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;VV:1–68. [Google Scholar]
- 14. Remington PL, Catlin BB, Gennuso KP. The County Health Rankings: rationale and methods. Popul Health Metr. 2015;13:11. DOI: 10.1186/s12963-015-0044-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples. Stat Med. 2009;28:3083–3107. DOI: 10.1002/sim.3697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Zeileis A, Kleiber C, Jackman S. Regression models for count data in R. J Stat Softw. 2008;2008:25. [Google Scholar]
- 17. R: a language and environment for statistical computing [computer program]. Version 3.5.1. Vienna, Austria; 2018.
- 18. Fiordelisi A, Piscitelli P, Trimarco B, Coscioni E, Iaccarino G, Sorriento D. The mechanisms of air pollution and particulate matter in cardiovascular diseases. Heart Fail Rev. 2017;22:337–347. DOI: 10.1007/s10741-017-9606-7. [DOI] [PubMed] [Google Scholar]
- 19. Simkhovich BZ, Kleinman MT, Kloner RA. Air pollution and cardiovascular injury. Epidemiol Toxicol Mech. 2008;52:719–726. DOI: 10.1016/j.jacc.2008.05.029. [DOI] [PubMed] [Google Scholar]
- 20. Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez‐Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, et al. Particulate matter air pollution and cardiovascular disease. Circulation. 2010;121:2331–2378. DOI: 10.1161/CIR.0b013e3181dbece1. [DOI] [PubMed] [Google Scholar]
- 21. Ranthe MF, Carstensen L, Øyen N, Tfelt‐Hansen J, Christiansen M, McKenna WJ, Wohlfahrt J, Melbye M, Boyd HA. Family history of premature death and risk of early onset cardiovascular disease. J Am Coll Cardiol. 2012;60:814–821. DOI: 10.1016/j.jacc.2012.06.018. [DOI] [PubMed] [Google Scholar]
- 22. Ward‐Caviness CK. A review of gene‐by‐air pollution interactions for cardiovascular disease, risk factors, and biomarkers. Hum Genet. 2019;138:547–561. DOI: 10.1007/s00439-019-02004-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. White N Jr. Hospital to home initiative‐reviewing the goals and challenges. US Cardiol Rev. 2011;8:84–87. DOI: 10.15420/usc.2011.8.2.84. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data S1
Tables S1–S5
Figures S1–S5
